Wall Street Analysts See a 28.68% Upside in West Pharmaceutical ( WST ) : Can the Stock Really Move This High?
The mean of analysts' price targets for West Pharmaceutical (WST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y
ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.
RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y
Rigetti posts a narrower adjusted Q2 loss and unveils its largest quantum computer, but revenue declines 41.6% year over year.
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
Surmodics delivers third-quarter fiscal 2025 earnings beat with narrower loss, as revenue tops estimates despite lower SurVeil DCB sales.
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
VEEV's strong first quarter, product innovations and strategic deals drive growth prospects despite rising costs.
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies
Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and The Cooper Companies are positioned for steady gains in the dental supplies space.
CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls
Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
Encompass Health Q2 Earnings Beat Estimates, Stock Up 7.4%
EHC posts strong Q2 with higher EPS, revenue growth, and a raised 2025 outlook, along with shares gaining 7.4%.
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y
INGN stock rises as Q2 loss narrows and revenue climbs 4% year over year, driven by strong B2B demand despite DTC and rental declines.
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
AMN Stock Slips Despite Q2 Earnings & Revenue Beat, Margins Down
AMN Healthcare tops second-quarter 2025 earnings and revenue forecasts, but margins and segment sales face continued pressure.
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve
SOLV jumps 5% as Q2 earnings and revenues beat estimates. EPS outlook raised on broad-based segment growth.
XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up
DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.
BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up
BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y
Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand
QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands
DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand
Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.
Select Medical Shares Down 20% Despite Q2 Earnings Beat
SEM beats Q2 EPS estimates on strong Rehab admissions and higher revenue per patient day. Yet, shares drop 20.4% post-earnings.
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised
Cencora posts strong Q3 results with earnings and revenues surpassing estimates. raises FY25 EPS guidance on robust U.S. segment growth.
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down
Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable.
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
TransMedics stock jumps 10.5% as Q2 EPS beats by 91.7%, revenue rises 37.7%, and operating margin expands 1230 basis points.
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
Glaukos' second-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CNMD reports solid second-quarter results, driven by improving sales across both segments.
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
MMSI beats second-quarter 2025 earnings estimates as gross margin expands and strong U.S. and Cardiovascular sales drive revenue growth.
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
Wall Street Analysts Think West Pharmaceutical ( WST ) Could Surge 25.26%: Read This Before Placing a Bet
The consensus price target hints at a 25.3% upside potential for West Pharmaceutical (WST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Ecolab Stock Down in Pre-Market Post Q2 Earnings Miss, Margins Expand
ECL stock dips in pre-market despite second-quarter 2025 earnings growth and margin expansion, as EPS misses estimates by a penny.
Kuehn Law Encourages Investors of West Pharmaceutical Services, Inc. to Contact Law Firm - West Pharmaceutical Servs ( NYSE:WST )
NEW YORK, July 29, 2025 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of West Pharmaceutical Services, Inc. WST breached their fiduciary duties to shareholders.
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
UNH misses Q2 earnings estimates as surging medical costs slash EPS 40%, despite revenue growth and Optum Rx strength.
Universal Health Q2 Earnings Beat on Strong Acute Care Admissions
UHS tops Q2 estimates with EPS up 24% as strong acute care and behavioral admissions drive revenue growth.
West Pharmaceutical ( WST ) Upgraded to Strong Buy: Here's Why
West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for July 28th
CALX, MEDP and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2025.
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week ( July 21-July 25 ) : Are The Others In Your Portfolio? - Astera Labs ( NASDAQ:ALAB ) , Baker Hughes ( NASDAQ:BKR )
Medpace surged over 137% after crushing Q2 earnings estimates. Strong earnings and raised guidance drove sharp gains in pharma and tech names. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily. These ten large-cap stocks were top performers last week.
West Pharma EPS Jumps 22 Percent in Q2
West Pharmaceutical Services ( NYSE:WST ) , a global manufacturer of drug packaging and delivery systems for the pharmaceutical and healthcare industries, reported Q2 2025 earnings on July 24, 2025. The key news was a significant beat on both GAAP revenue and non-GAAP EPS. Adjusted earnings per ...
Crude Oil Rises Over 1%; Alphabet Earnings Top Estimates - Community Health Sys ( NYSE:CYH ) , ReAlpha Tech ( NASDAQ:AIRE )
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.51% to 44,779.97 while the NASDAQ rose 0.11% to 21,044.05. The S&P 500 also rose, gaining, 0.12% to 6,366.84. Communication services shares jumped by 1% on ...
WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit
West Pharmaceutical's second-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday - Arrive AI ( NASDAQ:ARAI ) , ASGN ( NYSE:ASGN )
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Thursday. Shares of RPM International Inc. RPM rose sharply on Thursday following better-than-expected quarterly EPS and sales.
West Pharma Q2 Earnings - West Pharmaceutical Servs ( NYSE:WST )
Q2 EPS rose to $1.84 from $1.52, beating estimates; revenue hit $766.5 million vs. $726.45 million expected. The full-year EPS forecast rose to $6.65-$6.85; the sales outlook increased to $3.04 billion-$3.06 billion.
